Tag

Nurix Therapeutics

1 article

Roche signs $2.3B deal with Nurix

Roche and Nurix Therapeutics entered an exclusive licensing and collaboration agreement valued up to $2.3 billion for blood‑cancer drug bexobrutideg. Nurix will receive $700 million upfront, with furt